EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP ® )
2017 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP ® )
Petersen, I.; Dietel, M.; Geilenkeuser, W. J.; Mireskandari, M.; Weichert, W.; Steiger, K. & Scheel, A. H. et al. (2017)
Pathology - Research and Practice, 213(12) pp. 1530-1535. DOI: https://doi.org/10.1016/j.prp.2017.09.021
Documents & Media
Details
- Authors
- Petersen, Iver; Dietel, Manfred; Geilenkeuser, Wolf J.; Mireskandari, Masoud; Weichert, Wilko; Steiger, Katja; Scheel, Andreas H.; Büttner, Reinhard; Schirmacher, Peter; Warth, Arne; Lasitschka, Felix; Schildhaus, Hans-Ulrich ; Kirchner, Thomas; Reu, Simone; Kreipe, Hans; Länger, Florian; Tiemann, Markus; Schulte, Christoph; Jöhrens, Korinna
- Issue Date
- 2017
- Journal
- Pathology - Research and Practice
- ISSN
- 0344-0338
- Language
- English
